StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30111% above fair value
$56.30+1.31 (+2.38%)

Close on Nov 17, 2026Market cap $7.34BP/E –Yield –

10x Genomics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

10x Genomics's operating cash flow for the twelve months ending Sep 30, 2026 was $99.70M, up 12.6% year over year. For fiscal 2025 it was $136.05M, up 1941.6% from the year before. The highest annual figure on record is $136.05M in fiscal 2025.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$136.05M+1941.6%
FY2024Dec 31, 2024$6.66M–
FY2023Dec 31, 2023-$15.20M–
FY2022Dec 31, 2022-$33.61M–
FY2021Dec 31, 2021-$21.37M–
FY2020Dec 31, 2020-$217.90M-729.3%
FY2019Dec 31, 2019$34.63M–
FY2018Dec 31, 2018-$76.41M–
FY2017Dec 31, 2017-$10.70M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$15.83M-63.4%
Q2 FY2026Jun 30, 2026$16.97M-4.1%
Q1 FY2026Mar 31, 2026$26.12M-24.0%
Q4 FY2025Dec 31, 2025$40.78M–
Q3 FY2025Sep 30, 2025$43.21M+99.7%
Q2 FY2025Jun 30, 2025$17.71M+136.2%
Q1 FY2025Mar 31, 2025$34.35M–
Q4 FY2024Dec 31, 2024-$6.75M-126.2%
Q3 FY2024Sep 30, 2024$21.64M–
Q2 FY2024Jun 30, 2024$7.50M–
Q1 FY2024Mar 31, 2024-$15.73M–
Q4 FY2023Dec 31, 2023$25.76M+87.7%
Q3 FY2023Sep 30, 2023-$25.30M–
Q2 FY2023Jun 30, 2023-$11.53M–
Q1 FY2023Mar 31, 2023-$4.13M–
Q4 FY2022Dec 31, 2022$13.72M+136.4%
Q3 FY2022Sep 30, 2022-$9.56M–
Q2 FY2022Jun 30, 2022-$16.96M-643.7%
Q1 FY2022Mar 31, 2022-$20.80M–
Q4 FY2021Dec 31, 2021$5.81M–
Q3 FY2021Sep 30, 2021-$26.22M–
Q2 FY2021Jun 30, 2021$3.12M–
Q1 FY2021Mar 31, 2021-$4.08M–
Q4 FY2020Dec 31, 2020-$130.18M-2042.9%
Q3 FY2020Sep 30, 2020-$55.63M-483.0%
Q2 FY2020Jun 30, 2020-$29.52M-822.9%
Q1 FY2020Mar 31, 2020-$2.58M-127.6%
Q4 FY2019Dec 31, 2019$6.70M–
Q3 FY2019Sep 30, 2019$14.53M–
Q2 FY2019Jun 30, 2019$4.08M–
Q1 FY2019Mar 31, 2019$9.32M–
Q4 FY2018Dec 31, 2018-$51.00M–

More 10x Genomics figures

See a number that looks wrong?